Tenascin-C: Its functions as an integrin ligand

被引:89
|
作者
Tucker, Richard P. [1 ]
Chiquet-Ehrismann, Ruth [2 ,3 ]
机构
[1] Univ Calif Davis, Dept Cell Biol & Human Anat, Davis, CA 95616 USA
[2] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland
[3] Univ Basel, Fac Sci, CH-4056 Basel, Switzerland
基金
瑞士国家科学基金会;
关键词
Tenascin; Integrin; Extracellular matrix; RGD; IDG; ALTERNATIVELY SPLICED REGION; MEDIATES CELL ATTACHMENT; NEURITE OUTGROWTH; III REPEAT; RGD SITE; FIBRONECTIN; RECEPTOR; BINDING; FIBRINOGEN; CYTOTACTIN;
D O I
10.1016/j.biocel.2015.06.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This review summarizes the experimental evidence of tenascin-C/integrin interactions, emphasizing the identification of integrin binding sites and the effects of specific interactions on cell behavior. At least four integrins appear to bind to the third fibronectin-type 3 domain of tenascin-C: alpha 9 beta 1, alpha V beta 3, alpha 8 beta 1 and alpha V beta 6. The alpha 9 beta 1 integrin recognizes a highly conserved IDG motif in this domain, while the others recognize an RGD motif. There is also significant evidence that the collagen receptor a2 beta 1 can bind to tenascin-C, but the interacting site is unknown. Tenascin-C interactions with alpha 9 beta 1 and alpha V beta 3 can promote cell proliferation and interactions with alpha V beta 3 can also inhibit apoptosis. Interactions with alpha 7 beta 1 integrin, which may bind to the alternatively spliced domain of tenascin-C, and alpha 9 beta 1 integrin are able to influence the differentiation of mesenchymal stem cells into the neuronal lineage. This illustrates the potential for using our knowledge of tenascins and their integrin receptors in stem cell-based therapies. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:165 / 168
页数:4
相关论文
共 50 条
  • [41] How to detect and purify tenascin-C
    Giblin, Sean P.
    Murdamoothoo, Devadarssen
    Deligne, Claire
    Schwenzer, Anja
    Orend, Gertraud
    Midwood, Kim S.
    METHODS IN EXTRACELLULAR MATRIX BIOLOGY, 2018, 143 : 371 - 400
  • [42] Tenascin-C targeting strategies in cancer
    Dhaouadi, Sayda
    Bouhaouala-Zahar, Balkiss
    Orend, Gertraud
    MATRIX BIOLOGY, 2024, 130 : 1 - 19
  • [43] Tenascin-C induced signaling in cancer
    Orend, Gertraud
    Chiquet-Ehrismann, Ruth
    CANCER LETTERS, 2006, 244 (02) : 143 - 163
  • [44] Glycosaminoglycans modulate fibronectin matrix assembly and are essential for matrix incorporation of tenascin-C
    Chung, CY
    Erickson, HP
    JOURNAL OF CELL SCIENCE, 1997, 110 : 1413 - 1419
  • [45] Internal Affairs: Tenascin-C as a Clinically Relevant, Endogenous Driver of Innate Immunity
    Marzeda, Anna M.
    Midwood, Kim S.
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2018, 66 (04) : 289 - 304
  • [46] Involvement of integrin-activating peptides derived from tenascin-C in colon cancer progression
    Fujita, Motomichi
    Suzuki, Hideo
    Fukai, Fumio
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 13 (09) : 980 - 994
  • [47] Tenascin-C suppresses Rho activation
    Wenk, MB
    Midwood, KS
    Schwarzbauer, JE
    JOURNAL OF CELL BIOLOGY, 2000, 150 (04) : 913 - 919
  • [48] TENASCIN-R (J1-160/180) INHIBITS FIBRONECTIN-MEDIATED CELL-ADHESION - FUNCTIONAL RELATEDNESS TO TENASCIN-C
    PESHEVA, P
    PROBSTMEIER, R
    SKUBITZ, APN
    MCCARTHY, JB
    FURCHT, LT
    SCHACHNER, M
    JOURNAL OF CELL SCIENCE, 1994, 107 : 2323 - 2333
  • [49] Fibronectin and tenascin-C: accomplices in vascular morphogenesis during development and tumor growth
    Van Obberghen-Schilling, Ellen
    Tucker, Richard P.
    Saupe, Falk
    Gasser, Isabelle
    Cseh, Botond
    Orend, Gertraud
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY, 2011, 55 (4-5) : 511 - 525
  • [50] Effects of tenascin-C in cultured hippocampal astrocytes: NCAM and fibronectin immunoreactivity changes
    Mahler, M
    Ferhat, L
    BenAri, Y
    Represa, A
    GLIA, 1997, 20 (03) : 231 - 242